Dear HIFA colleagues,
HIFA recently hosted a discussion on Open Access sponsored by Oxxford Pharmagenesis where APC capping (whereby funders will only pay for APC up to a certain amount) was one of the main recommendations. Here is a blog we published at the time: https://www.hifa.org/news/what-we-learned-about-open-access-publishing-h...
I was intereseted to see this blog on Scholarly Kitchen:
https://scholarlykitchen.sspnet.org/2026/05/14/apc-caps-and-bans-why-fun...
Interesting blog but I'm not clear what is the #1 reason why APC capping would not work. What *are* the options for reducing the phenomenal APCs that some publishers charge?
Best wishes, Neil
HIFA profile: Neil Pakenham-Walsh is coordinator of HIFA (Healthcare Information For All), a global health community that brings all stakeholders together around the shared goal of universal access to reliable healthcare information. HIFA has 20,000 members in 180 countries, interacting in four languages and representing all parts of the global evidence ecosystem. HIFA is administered by Global Healthcare Information Network, a UK-based nonprofit in official relations with the World Health Organization. Email: neil@hifa.org